Dr. Abud Bakri

Because now that everyone's getting like these Pannulo scans and different full-bed MRIs, we can see the thymus size.

We always have a patient that comes in, you know, car accident, young 45-year-old car accident, comes in, has a pancreatic mass.

They would have never known about had they not had that accident.

They get a CT scan just to check for any kind of internal bleeding.

They find the pancreatic mass.

That gets removed.

It ends up being a malignant mass that had they waited six months, they would have, you know, had stage four pancreatic cancer and passed away.

So that's the theory.

There is a concern about false positives and false negatives when it comes to these screening modalities.

Like any screening modality is not perfect.

So there's a big debate on whether or not to do these that will leave to people and their physicians.

But I've been trying to lobby them to give the thymic score to everybody who gets one of these scans.

Right.

Because they could see, like, hey, can you see where the thymus is at?

Because, you know, someone might come in, you know, for five different scans over five years.

They did a TRT protocol or a GH protocol or whatever it may be.

And we could see, did that improve thymic status or make it worse or different infections, different interventions?

That'd be very interesting to kind of tease out.

On blood tests, we've been trying to work with a couple different labs to figure out a thymic score.

Mm-hmm.